Akrivis Technologies LLC is categorized under Diagnostic Substances in Cambridge, MA and active since 2009.
Akrivis Technologies LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Diagnostic Substances business, which does work in the B2B market, and is classified as a Diagnostic Substances, under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact Joel A Berniac at the company’s single location by writing to 1 Broadway Floor 14, Cambridge, Massachusetts MA 02142 or by phoning (617) 233-4097. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Akrivis Technologies LLC |
| Contact Person: | Joel A Berniac |
| Address: | 1 Broadway Floor 14, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 233-4097 |
| Website Address: | akrivis.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Diagnostic Substances |
| SIC Code: | 2835 |
| NAICS Code: | 325412 |
| Share This Business: |
Akrivis Technologies LLC was started in 2009 to provide professional Diagnostic Substances under the SIC code 2835 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joel A Berniac for inquiries that concern Akrivis Technologies LLC by calling the company number (617) 233-4097, as your correspondence is most welcome. Additionally, the physical location of the single location of Akrivis Technologies LLC can be found at the coordinates 42.362362,-71.083313 as well as the street address 1 Broadway Floor 14 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Akrivis Technologies LLC’s website at akrivis.com and engage with its social media outlets through on Twitter and on Facebook.